Solana recorded $977 million in weekly tokenized-equity decentralized exchange (DEX) volume, leading blockchain rankings for the second consecutive week. Tokenized equities are blockchain-based instruments linked to traditional stocks, and their trading on DEXs reflects growing interest in digital asset markets. In Q3, Solana ranked third behind BNB Chain and Robinhood Chain, with tokenized equities making up about 9% of the $571 billion spot DEX volume that quarter. This weekly figure highlights Solana's strong recent performance in the tokenized equity space, signaling continued momentum in blockchain trading platforms.
Solana's tokenized-equity DEX trading volume reached $977 million in a recent week, showing strong activity in digital asset markets. For readers following cryptocurrency market breadth on Pluang, 7 of 50 major cryptocurrencies rose while 42 fell, with GRT at Rp358 (-3.08%), YFI at Rp35,420,568 (-2.95%), and VET at Rp104 (-2.52%). These figures are as of Nov 02, 2026 19:42 WIB.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
